• Latest
  • Trending
AstraZeneca’s ‘Mistake’ in Covid Vaccine Trials Could Halt Approval

AstraZeneca’s ‘Mistake’ in Covid Vaccine Trials Could Halt Approval

November 27, 2020
Nigeria’s Southwest Governors Agree With Cattle Breeders to Ban Open Grazing

Nigeria’s Southwest Governors Agree With Cattle Breeders to Ban Open Grazing

January 25, 2021
Nigeria: Several Feared Dead in Clash Between Soldiers and Seperarist Group; Imo Governor Imposes Curfew

Nigeria: Several Feared Dead in Clash Between Soldiers and Seperarist Group; Imo Governor Imposes Curfew

January 25, 2021
Nigeria: Several Feared Dead in Clash Between Soldiers and Seperarist Group; Imo Governor Imposes Curfew

Nigeria: Several Feared Dead in Clash Between Soldiers and Seperarist Group; Imo Governor Imposes Curfew

January 25, 2021
Wizkid Retains Number One Spot on UK Afrobeats Chart With ‘Ginger’

Wizkid Retains Number One Spot on UK Afrobeats Chart With ‘Ginger’

January 25, 2021
Covid: Dutch PM Mark Rutte Condemns Curfew Riots as ‘Criminal Violence’         

Covid: Dutch PM Mark Rutte Condemns Curfew Riots as ‘Criminal Violence’      

January 25, 2021
West African Presidents Express Concern Over Growing Terrorism, Piracy in Region 

West African Presidents Express Concern Over Growing Terrorism, Piracy in Region 

January 25, 2021
US Regulators Say Moderna Vaccine is Highly Effective, Paving Way for Approval

Moderna Vaccine Appears to Work against New Covid Variants

January 25, 2021
ICC, Human Rights Groups Aggravating Nigeria’s Security Challenges, Government Claims

In the Face Growing Insecurity, Nigerian Government Says ‘Security Situation Better than in 2015’

January 25, 2021

ARISE NEWSDAY

January 25, 2021
Kagame Calls for Inclusive Global Response in Tackling Pandemic

Kagame Calls for Inclusive Global Response in Tackling Pandemic

January 25, 2021
Eleven Dead After Heavy Fighting Near Somalia-Kenya Border

Eleven Dead After Heavy Fighting Near Somalia-Kenya Border

January 25, 2021
Promising to Defeat Al-Shabab, Kenya, UK Agree to Refresh Security Compact

Promising to Defeat Al-Shabab, Kenya, UK Agree to Refresh Security Compact

January 25, 2021
Nigerian Governors Back Akeredolu, Say He  Didn’t Ask Herdsmen to Vacate Ondo State

Nigerian Governors Back Akeredolu, Say He Didn’t Ask Herdsmen to Vacate Ondo State

January 25, 2021
Trey Songz Arrested After Fight with Police Officer

Trey Songz Arrested After Fight with Police Officer

January 25, 2021
French President Macron Promotes Recovery Plan to Business Leaders

French President Macron Promotes Recovery Plan to Business Leaders

January 25, 2021
Ex-Trump Spokeswoman Sarah Sanders Running for Arkansas Governor

Ex-Trump Spokeswoman Sarah Sanders Running for Arkansas Governor

January 25, 2021
Chinese Rescuers Hope to Drill Shaft to Free Trapped Gold Miners

Nine Workers Found Dead in China Gold Mine Rescue

January 25, 2021
Zimbabwe Doctors Protest Against ‘Medical Assassins’ Slur

Zimbabwe Doctors Protest Against ‘Medical Assassins’ Slur

January 25, 2021
Cuban Doctors Arrive in Mozambique to Battle Covid-19

Cuban Doctors Arrive in Mozambique to Battle Covid-19

January 25, 2021
Lampard Says there are Lessons to be Learned after Chelsea’s 3-3 Draw with West Brom

‘This Has Been a Difficult Decision’: Chelsea Sack Lampard as Head Coach

January 25, 2021

Global Business Report

January 25, 2021
US Passes 25m Covid Cases, Over a Quarter of World’s Infections

Morning Show

January 25, 2021

Nigeria: Governor Akeredolu’s Quit Notice to Fulani Herders Irresponsible, Says Former Health Insurance Boss

January 25, 2021
Chelsea Set to Replace Lampard with Tuchel

Chelsea Set to Replace Lampard with Tuchel

January 25, 2021
President Biden Signs Orders for US to Rejoin Climate Deal and WHO, End ‘Muslim Ban’

Biden to Re-instate Covid-19 Travel Restrictions

January 25, 2021
India, China Troops in New Clash Along Contested Border

India, China Troops in New Clash Along Contested Border

January 25, 2021
Handlers of President Buhari ‘Pursuing Fulani Worldwide Interest’, Former Nigerian Colonel Says

Handlers of President Buhari ‘Pursuing Fulani Worldwide Interest’, Former Nigerian Colonel Says

January 25, 2021
US Envoy ‘Turned Away’ from Bobi Wine’s Home

Ugandan Court Orders End to Opposition Leader Bobi Wine’s House Arrest

January 25, 2021
Mexican President López Obrador Tests Positive for Covid-19

Mexican President López Obrador Tests Positive for Covid-19

January 25, 2021
US House Lawmakers Set to Impeach Trump For Historic 2nd Time

US House to Deliver Trump Impeachment Charge to Senate Monday

January 25, 2021
en English
ar Arabiczh-CN Chinese (Simplified)nl Dutchen Englishfr Frenchde Germanit Italianpt Portugueseru Russianes Spanish
No Result
View All Result
Tuesday, January 26, 2021
Arise News
  • HOME
  • Breaking
  • Global
  • Regional
  • US ELECTION
  • BUSINESS
  • Politics
  • Entertainment
  • Sports
  • TECH
  • Health
  • VIDEOS
  • Covid-19 Updates
Arise News
  • HOME
  • Breaking
  • Global
  • Regional
  • US ELECTION
  • BUSINESS
  • Politics
  • Entertainment
  • Sports
  • TECH
  • Health
  • VIDEOS
  • Covid-19 Updates
No Result
View All Result
Arise News
No Result
View All Result
Home Global

AstraZeneca’s ‘Mistake’ in Covid Vaccine Trials Could Halt Approval

November 27, 2020
Reading Time: 4min
0 0
0
AstraZeneca’s ‘Mistake’ in Covid Vaccine Trials Could Halt Approval
Share on FacebookShare on Twitter

AstraZeneca’s coronavirus vaccine is coming under intense scrutiny after its UK scientists made a major “mistake” during trials — one that could even halt it from getting approved, according to reports.

The UK drugmaker and its partner, Oxford University, admitted — after reporting its vaccine tested up to 90% effective — that the promising results came after a batch of volunteers were accidentally given half doses. The efficacy of the vaccine was significantly lower at 62% for those who received the correctly administered two full doses.

Lead researcher Mene Pangalos insisted it was “serendipity,” but the error, which was not reported in the initial findings, has brought the vaccine under intense scrutiny from scientists and industry experts.

The half-dose group was just 2,741 volunteers — and all were under 55, raising questions as to whether the relative youth of the participants created the positive results, not the size of the dose.

“It pains me to say this, but… I think the claims made for the Oxford/AstraZeneca Covid-19 vaccine are on very shaky ground. We should wait for a solid large trial,” scientist Hilda Bastian tweeted after the testers’ confessions.

“They have solid data for a relatively weak vaccine and weaker data for a relatively strong one,” he warned of the low numbers accidentally given the half-dosage.

“This is really not being handled well at all … it’s a good thing this wasn’t the first vaccine to read out,” he added, referring to earlier vaccine test announcements from Pfizer and Moderna.

The former head of research and development at one of those rivals, Pfizer, questioned whether it would derail the AstraZeneca vaccine getting approved.

“Hard to believe that the [US Food and Drug Administration] will issue [emergency use] for a vaccine whose optimal dose has only been given to 2,300 people,” Dr. John LaMattina tweeted. “More data for this dosing regiment will be needed.”

Natalie Dean, a biostatistician and an expert in vaccine trial design at the University of Florida, gave the UK team “a poor grade for transparency and rigor.”

“It is awfully confusing for experts and non-experts alike,” she wrote.

The error and confusion over results caused shares in the company to slump 6.2 percent as industry experts also lose confidence, according to Bloomberg News.

“Any time you have confusion in trials it’s not a good thing because it effectively removes any kind of credibility you had,” Ketan Patel, a fund manager at EdenTree Investment Management, told Bloomberg.

“I think there will be a lot more scrutiny of Astra’s product due to the manufacturing issue.”

Geoffrey Porges, an SVB Leerink analyst, was another to predict that it could be enough to prevent the FDA from approving the vaccine for use.

“I don’t believe that the FDA will look positively at any trial where the dose, or the age cohorts, or any other variable were changed mid-trial, inadvertently or deliberately,” Porges told Bloomberg News. “I think that they have really damaged confidence in their whole development program,” he told The Times.

Other experts are also concerned at the suggestion that the low-dose group raised the overall effectiveness to 70%.

“You’ve taken two studies for which different doses were used and come up with a composite that doesn’t represent either of the doses,″ said David Salisbury, an associate fellow of the global health program at the Chatham House think tank. “I think many people are having trouble with that.″

A spokesman for Astra told Bloomberg that the trials were conducted “to the highest standards” and more analysis is being done to refine the efficacy reading.

  • About
  • Advertise
  • Privacy & Policy
  • Contact

© 2020 Arise News - Part of the Arise Media Group.

No Result
View All Result
  • HOME
  • Breaking
  • Global
  • Regional
  • US ELECTION
  • BUSINESS
  • Politics
  • Entertainment
  • Sports
  • TECH
  • Health
  • VIDEOS
  • Covid-19 Updates

© 2020 Arise News - Part of the Arise Media Group.

Welcome Back!

Login to your account below

Forgotten Password?

Create New Account!

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist